[Skip to Navigation]
Views 273
Citations 0
Comment & Response
March 2017

Appropriate Treatment of T3 Glottic Cancer

Author Affiliations
  • 1Department of Otolaryngology–Head & Neck Surgery, Carlo Poma Civil Hospital, Mantova, Italy
JAMA Otolaryngol Head Neck Surg. 2017;143(3):317-318. doi:10.1001/jamaoto.2016.3235

To the Editor We read the article “Surgical vs Nonsurgical Treatment Modalities for T3 Glottic Squamous Cell Carcinoma” by Al-Gilani et al1 and we congratulate the authors; however, some potentially misleading details may be found in their article.

First, the T3 glottic cancer category includes heterogeneous subcategories with different extension (vocal cord fixation and/or paraglottic space invasion, and/or minor thyroid cartilage erosion).2 When comparing oncological and/or functional outcomes among patients treated for T3 glottic squamous cell carcinoma (SCC), the results should be analyzed separately for the different subgroups.2,3

Add or change institution